About Frank Sciavolino
Frank Sciavolino is a director at Thetis Pharmaceuticals.
Frank Sciavolino first appears on SEC filings in 2011.
Experience
This experience comes from Frank Sciavolino's profile and from SEC filings. For roles taken from filings, the years are when the filings name Frank Sciavolino in the role, so the role may have started earlier or lasted longer.
Thetis Pharmaceuticals LLC Current
Co-Founder, President & Chief Scientific Officer (2011 – Present)
Director
2011 – Present · Deep River, CT
Develops oral medicines for people with inflammatory bowel disease and solid tumors.
EV
Elm Street Ventures
Senior Advisor
2010 – 2012
MA
Max Zeller Soehne AG
Senior Advisor
2010 – 2012
IP
Indigene Pharmaceuticals
EVP, Global Research & Development
2003 – 2010
PI
Pfizer Inc
VP, Research & Development
1967 – 2003
TH
The White House
Commission on C&A Medicine
1999 – 2001
Key Colleagues at Startups
The people Frank Sciavolino works with at each company, as listed on that company's latest Form D.
Thetis Pharmaceuticals LLC · Form D, Oct 13, 2026
GM
Gary Mathias
Chief Executive Officer and director
WO
Walter Ogier
Director
DW
Dennis Willson
Director
FC
Fabio Cataldi
Director
DC
David Cook
Director